Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-02-22 2021-02-22
Drug Identification Number 02195968 02195968
Brand name APO-LEVOCARB - TAB 25MG/250MG APO-LEVOCARB - TAB 25MG/250MG
Common or Proper name LEVOCARB LEVOCARB
Company Name APOTEX INC APOTEX INC
Ingredients CARBIDOPA LEVODOPA CARBIDOPA LEVODOPA
Strength(s) 25MG 250MG 25MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N04BA N04BA
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-23 2020-12-23
Estimated end date 2021-02-19 2021-02-19
Actual end date 2021-02-18 2021-02-18
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments